UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

8 Apr 2019

Transparency notification BlackRock, Inc.

Read More
4 Apr 2019

Acquisition of own shares

Read More
2 Apr 2019

Transparency notifications BlackRock, Inc.

Read More
31 Mar 2019

UCB to provide additional information to the US FDA regarding midazolam nasal spray submission

Read More
29 Mar 2019

Transparency notification BlackRock, Inc.

Read More
28 Mar 2019

CIMZIA® (certolizumab pegol) is Now the First and Only U.S. FDA-Approved Treatment for Non-Radiographic Axial Spondyloarthritis 

Read More

Stay up-to-date on the latest news and information from UCB